CorMedix Statistics
Total Valuation
CorMedix has a market cap or net worth of $255.56 million. The enterprise value is $197.57 million.
| Market Cap | 255.56M |
| Enterprise Value | 197.57M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CorMedix has 54.96 million shares outstanding. The number of shares has increased by 30.42% in one year.
| Shares Outstanding | 54.96M |
| Shares Change (YoY) | +30.42% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | 31.86% |
| Float | 54.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 6.74 |
| PB Ratio | 4.41 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.65, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.65 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,459.41 |
Financial Efficiency
Return on equity (ROE) is -77.20% and return on invested capital (ROIC) is -93.18%.
| Return on Equity (ROE) | -77.20% |
| Return on Assets (ROA) | -67.30% |
| Return on Capital (ROIC) | -93.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$605,279 |
| Employee Count | 83 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.41% in the last 52 weeks. The beta is 1.60, so CorMedix's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +21.41% |
| 50-Day Moving Average | 4.85 |
| 200-Day Moving Average | 4.04 |
| Relative Strength Index (RSI) | 50.21 |
| Average Volume (20 Days) | 443,025 |
Short Selling Information
The latest short interest is 9.81 million, so 17.85% of the outstanding shares have been sold short.
| Short Interest | 9.81M |
| Short Previous Month | 9.97M |
| Short % of Shares Out | 17.85% |
| Short % of Float | 18.03% |
| Short Ratio (days to cover) | 19.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | -818,539 |
| Operating Income | -54.64M |
| Pretax Income | -51.63M |
| Net Income | -50.24M |
| EBITDA | -51.52M |
| EBIT | -51.60M |
| Earnings Per Share (EPS) | -$0.93 |
Balance Sheet
The company has $58.63 million in cash and $631,389 in debt, giving a net cash position of $58.00 million or $1.06 per share.
| Cash & Cash Equivalents | 58.63M |
| Total Debt | 631,389 |
| Net Cash | 58.00M |
| Net Cash Per Share | $1.06 |
| Equity (Book Value) | 58.01M |
| Book Value Per Share | 1.06 |
| Working Capital | 53.88M |
Cash Flow
In the last 12 months, operating cash flow was -$45.33 million and capital expenditures -$373,840, giving a free cash flow of -$45.70 million.
| Operating Cash Flow | -45.33M |
| Capital Expenditures | -373,840 |
| Free Cash Flow | -45.70M |
| FCF Per Share | -$0.80 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CorMedix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.42% |
| Shareholder Yield | -30.42% |
| Earnings Yield | -19.66% |
| FCF Yield | -17.88% |
Analyst Forecast
The average price target for CorMedix is $13.00, which is 179.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 179.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 26, 2019. It was a reverse split with a ratio of 1:5.
| Last Split Date | Mar 26, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |